Close

Poseida Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares Aug 8, 2022 04:05PM
Poseida Therapeutics (PSTX) Prices 20M Share Offering at $3.50/sh Aug 4, 2022 08:01AM
Poseida Therapeutics Announces Pricing of Public Offering of Common Stock Aug 4, 2022 08:00AM
Poseida Therapeutics (PSTX) Announces Proposed Stock Offering, Size not Disclosed Aug 4, 2022 07:01AM
Poseida Therapeutics Announces Proposed Public Offering of Common Stock Aug 4, 2022 07:00AM


Aug 3, 2022 04:01PM Poseida Therapeutics (PSTX) Announces Proposed Stock Offering, Size not Disclosed
Aug 3, 2022 04:01PM Poseida Therapeutics Announces Proposed Public Offering of Common Stock
May 13, 2022 04:18PM Cantor Fitzgerald Assumes Poseida Therapeutics, Inc (PSTX) at Overweight
Feb 18, 2022 06:36AM Cantor Fitzgerald Starts Poseida Therapeutics, Inc (PSTX) at Overweight
Sep 7, 2021 08:00AM Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences